Larvol Delta - Allakos-Announces-AK002-Met-All-Prespecified-Primary-and-Secondary-Endpoints-in-Phase-2-Randomized-DoubleBlind-PlaceboControlled-Study-in-Patients-with-Eosinophilic-Gastritis-EG-andor-Eosinophilic-Gastroenteritis-EGE

AK002 - Allakos

http://www.globenewswire.com/news-release/2019/08/05/1896758/0/en/Allakos-Announces-AK002-Met-All-Prespecified-Primary-and-Secondary-Endpoints-in-Phase-2-Randomized-Double-Blind-Placebo-Controlled-Study-in-Patients-with-Eosinophilic-Gastritis-EG-.html

Aug 5, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next